ArticleDisease markers2022

Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer.

Kai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.